Previous 10 | Next 10 |
RxSight, Inc. (RXST) Q3 2021 Earnings Conference Call November 10, 2021, 16:30 PM ET Company Participants Ron Kurtz - Chief Executive Officer Shelley Thunen - Chief Financial Officer Conference Call Participants Ryan Zimmerman - BTIG Disclaimer*: This transcript is designed to be used alongsi...
RxSight (NASDAQ:RXST): Q3 Non-GAAP EPS of -$0.65 beats by $0.01; GAAP EPS of -$0.68 misses by $0.06. Revenue of $5.78M (+38.6% Y/Y) beats by $0.63M. Press Release For further details see: RxSight EPS beats by $0.01, beats on revenue
ALISO VIEJO, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today reported financial results for the three months ended September 30, 2021. Rec...
ALISO VIEJO, Calif., Oct. 27, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company, today announced that it will report financial results for the third quarter of 2021 after the market close on Wednesday, November 10, 2021. The company’s management will discus...
Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify. The major averages closed near sessions lows, with the S&P 500 (SP500), -0.8%, logging five straight losing days for the first time since...
ALISO VIEJO, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today reported financial results for the three months ended June 30, 2021. Recent Highlights ...
ALISO VIEJO, Calif., Sept. 01, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc., (NASDAQ: RXST) an ophthalmic medical device company, today announced an updated date for reporting second quarter 2021 financial results. In observance of the Rosh Hashanah holiday, the company will now report after the ...
ALISO VIEJO, Calif., Aug. 31, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST), an ophthalmic medical device company, today announced plans to participate in the upcoming virtual Wells Fargo Healthcare Conference. RxSight’s management is scheduled to present Friday, Septem...
RxSight has commercialized the first and only FDA approved customizable intraocular lens. The Company closed an IPO recently with gross proceeds of $132 million. Analysts are very bullish with the company’s prospects. For further details see: RxSight: First And On...
ALISO VIEJO, Calif., Aug. 24, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company, today announced that it will report financial results for the second quarter of 2021 after the market close on Tuesday, September 7, 2021. The company’s management will discuss...
News, Short Squeeze, Breakout and More Instantly...
ALISO VIEJO, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it will report financial results for the second...
ALISO VIEJO, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Truist Securities MedTech Conference. ...
Shareholders approved all agenda items and proposals of the Board of Directors Robert K. Warner, M.B.A. and Arshad M. Khanani, M.D., M.A., FASRS elected as members of the Board of Directors Baruch D. Kuppermann, M.D., Ph.D. and Frank G. Holz, M.D., Ph.D. appointed as members of th...